InnoCan Pharma ( ($TSE:INNO) ) has issued an announcement. Innocan Pharma’s subsidiary, BI Sky Global, has completed the Human Repeated Insult ...

Novartis AG (NYSE:NVS), a global healthcare company valued at over $206 billion, has undergone significant transformation in recent years, focusing its efforts on becoming a pure-play pharmaceutical ...

HERZLIYA, Israel and CALGARY, AB, Jan. 29, 2025 /PRNewswire/ -- Innocan Pharma Corporation (CSE: INNO) (FSE: IP4) (OTCQB: INNPF) ("Innocan" or the "Company"), a pioneer in the pharmaceutical ...

We recently published a list of 12 Best Depressed Stocks to Invest in Now. In this article, we are going to take a look at ...

Three players in the biosimilar space have already sparked hope for the new year, with each having big business or regulatory ...

Alliance Global Partners initiated coverage of CNS Pharmaceuticals (CNSP) with a Buy rating and $4 price target CNS is a clinical-stage ...

The global cannabis pharmaceuticals market is poised for exponential growth, with projections indicating an increase from $3.46 billion in 2023 to $380.77 billion by 2034. This remarkable expansion, ...

Researchers discovered alarmingly high amounts of pharmaceutical pollution, including Fentanyl, in dolphins' blubber.

One of the world's biggest global health funders will ask the private sector for a steep increase in donations as concern of ...

Trump drops the ax on a corporate-tax deal whacking U.S. firms.

Ascentage Pharma said on Tuesday it was targeting a valuation of $1.75 billion in its initial public offering, becoming the first sizeable Chinese firm to pursue a listing in the U.S. this year.

Uniphar, a global partner to pharmaceutical and medtech manufacturers, has appointed Isaac Batley as Global Head of Medical ...